These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21059626)

  • 1. Levetiracetam in chronic daily headache: a double-blind, randomised placebo-controlled study. (The Australian KEPPRA Headache Trial [AUS-KHT]).
    Beran RG; Spira PJ
    Cephalalgia; 2011 Apr; 31(5):530-6. PubMed ID: 21059626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of single-dose propofol injection on pain and quality of life in chronic daily headache: a randomized, double-blind, controlled trial.
    Simmonds MK; Rashiq S; Sobolev IA; Dick BD; Gray DP; Stewart BJ; Jamieson-Lega KI
    Anesth Analg; 2009 Dec; 109(6):1972-80. PubMed ID: 19923528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anticonvulsant levetiracetam for the treatment of pain in polyneuropathy: a randomized, placebo-controlled, cross-over trial.
    Holbech JV; Otto M; Bach FW; Jensen TS; Sindrup SH
    Eur J Pain; 2011 Jul; 15(6):608-14. PubMed ID: 21183370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
    Wu XY; Hong Z; Wu X; Wu LW; Wang XF; Zhou D; Zhao ZX; Lv CZ
    Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
    Peltola J; Coetzee C; Jiménez F; Litovchenko T; Ramaratnam S; Zaslavaskiy L; Lu ZS; Sykes DM;
    Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
    Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam in Compare to Sodium Valproate for Prophylaxis in Chronic Migraine Headache: A Randomized Double-Blind Clinical Trial.
    Kashipazha D; Ghadikolaei HS; Siavashi M
    Curr Clin Pharmacol; 2017; 12(1):55-59. PubMed ID: 28356053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levetiracetam in spinal cord injury pain: a randomized controlled trial.
    Finnerup NB; Grydehøj J; Bing J; Johannesen IL; Biering-Sørensen F; Sindrup SH; Jensen TS
    Spinal Cord; 2009 Dec; 47(12):861-7. PubMed ID: 19506571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.
    Steinhoff BJ; Somerville ER; Van Paesschen W; Ryvlin P; Schelstraete I
    Epilepsy Res; 2007 Aug; 76(1):6-14. PubMed ID: 17681453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive inpatient treatment of refractory chronic daily headache.
    Lake AE; Saper JR; Hamel RL
    Headache; 2009 Apr; 49(4):555-62. PubMed ID: 19245391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levetiracetam extended release and levetiracetam immediate release as adjunctive treatment for partial-onset seizures: an indirect comparison of treatment-emergent adverse events using meta-analytic techniques.
    Richy FF; Banerjee S; Brabant Y; Helmers S
    Epilepsy Behav; 2009 Oct; 16(2):240-5. PubMed ID: 19699156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Levisohn PM; Mintz M; Hunter SJ; Yang H; Jones J;
    Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies.
    Rosenfeld WE; Benbadis S; Edrich P; Tassinari CA; Hirsch E
    Epilepsy Res; 2009 Jul; 85(1):72-80. PubMed ID: 19327967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amitriptyline in the prophylactic treatment of migraine and chronic daily headache.
    Couch JR;
    Headache; 2011 Jan; 51(1):33-51. PubMed ID: 21070231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
    Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
    Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of levetiracetam in the treatment of lumbar radiculopathy: an open-label prospective cohort study.
    Hamza MS; Anderson DG; Snyder JW; Deschner S; Cifu DX
    PM R; 2009 Apr; 1(4):335-9. PubMed ID: 19627916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carthami-Semen acupuncture point injection for chronic daily headache: a pilot, randomised, double-blind, controlled trial.
    Park JM; Park SU; Jung WS; Moon SK
    Complement Ther Med; 2011 Jan; 19 Suppl 1():S19-25. PubMed ID: 21195291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levetiracetam in patients with central neuropathic post-stroke pain--a randomized, double-blind, placebo-controlled trial.
    Jungehulsing GJ; Israel H; Safar N; Taskin B; Nolte CH; Brunecker P; Wernecke KD; Villringer A
    Eur J Neurol; 2013 Feb; 20(2):331-7. PubMed ID: 22925226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of medication use by chronic and episodic headache sufferers in the general population: results from the frequent headache epidemiology study.
    Scher AI; Lipton RB; Stewart WF; Bigal M
    Cephalalgia; 2010 Mar; 30(3):321-8. PubMed ID: 19614708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.